TABLE 1

Pharmacokinetic parameters after single i.v. injection of PH, IMP and CHZ.

Data are expressed as the mean (n = 4–6).

Substrate (or Metabolite)ParameterControlSensitization
PS7SS7
PHλ (min−1)0.16 ± 0.030.15 ± 0.030.14 ± 0.01
AUC (μM·min)266.5 ± 79.1183.0 ± 44.8207.2 ± 31.9
T1/2 (min)4.60 ± 1.274.91 ± 0.814.97 ± 0.37
CLtot (ml/min/kg)113.4 ± 29.8161.0 ± 35.2137.9 ± 21.7
Vd (l/kg)0.89 ± 0.261.19 ± 0.410.66 ± 0.24
APAPAUC (μM·min)375.3 ± 16.9166.1 ± 22.9a216.7 ± 25.6a
IMPA (nmol/ml)2.59 ± 0.173.91 ± 0.45a3.52 ± 0.73a
α (min−1)0.033 ± 0.0110.055 ± 0.0070.040 ± 0.009
B (nmol/ml)1.62 ± 0.312.02 ± 0.851.48 ± 0.18
β (min−1)0.017 ± 0.0070.031 ± 0.0110.022 ± 0.002
CLtot (ml/min/kg)157.9 ± 19.5189.0 ± 6.1177.9 ± 14.8
AUC (μM·min)101.7 ± 13.583.7 ± 2.789.4 ± 7.8
Vdss (l/kg)b7.04 ± 0.574.47 ± 0.92a4.72 ± 0.64a
CHZλ (min−1)0.22 ± 0.040.14 ± 0.01a0.11 ± 0.01a
AUC (μM·min)859.9 ± 124.51145.8 ± 57.6a1134.6 ± 86.9a
T1/2 (min)3.16 ± 0.474.86 ± 0.29a6.46 ± 0.23a
CLtot (ml/min/kg)35.1 ± 5.325.8 ± 1.3a25.9 ± 1.8a
Vd (l/kg)0.13 ± 0.040.18 ± 0.010.20 ± 0.03
  • AUMC, the area under the first moment curve; Vdss, apparent volume of distribution at steady state. T1/2, half-life.

  • a Significantly different from the control mice; * P < 0.05.

  • b Calculated by Vdss = dose × AUMC/(AUC)2.